Loading institutional data...
Loading institutional data...
Held by 2,375 of 5,944 reporting institutions (100th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $858.2B | 39.4× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.1B | 49.1× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $378.1B | 28.9× | 24.8× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $345.5B | 22.6× | 16.3× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $298.3B | 26.4× | 17.4× | 7.3× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $183.9B | 22.4× | 15.0× | 2.0× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $117.4B | 17.0× | 13.6× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $80.7B | 33.0× | 18.9× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $70.0B | 19.0× | 10.2× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $69.7B | 33.1× | 19.4× | 3.4× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.6B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $43.2B | 20.8× | 14.5× | 2.6× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| FMX | $41.2B | — | — | — | — | — | — | — | — | — | 290 |
| ADM | $41.1B | 38.1× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| JBS | $40.2B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.9B | 39.7× | 10.0× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.4B | 21.1× | 9.6× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| HSY | $34.6B | — | 20.3× | 3.0× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| EL | $34.4B | — | 782.5× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KVUE | $34.2B | 23.5× | 11.6× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| KMB | $32.6B | 16.2× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $29.3B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.1B | 18.0× | 8.0× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.6B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.2B | 31.6× | 18.9× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
Peers = companies sharing MO's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.28B 100.0% | $24.02B 100.0% | $24.48B 100.0% | $25.10B 100.0% | $26.01B 100.0% | $26.15B 100.0% | $25.11B 100.0% | $25.36B 100.0% | $25.58B 100.0% | $25.74B 100.0% |
| Cost of Revenue | $5.60B 24.0% | $6.08B 25.3% | $6.22B 25.4% | $6.44B 25.7% | $7.12B 27.4% | $7.82B 29.9% | $7.08B 28.2% | $7.37B 29.1% | $7.53B 29.4% | $7.76B 30.2% |
| Cost of Products | — | — | — | — | — | — | — | — | $7.54B 29.5% | $7.75B 30.1% |
| Gross Profit | $14.54B 62.5% | $14.37B 59.8% | $14.28B 58.3% | $14.25B 56.8% | $13.99B 53.8% | $13.02B 49.8% | $12.71B 50.6% | $12.25B 48.3% | $11.96B 46.8% | $11.57B 45.0% |
| Research & Development | $195.0M 0.8% | $208.0M 0.9% | $220.0M 0.9% | $162.0M 0.6% | $145.0M 0.6% | $131.0M 0.5% | $168.0M 0.7% | $252.0M 1.0% | $241.0M 0.9% | $203.0M 0.8% |
| Operating Income | $9.90B 42.5% | $11.24B 46.8% | $11.55B 47.2% | $11.92B 47.5% | $11.56B 44.4% | $10.87B 41.6% | $10.33B 41.1% | $9.12B 35.9% | $9.59B 37.5% | $8.76B 34.0% |
| Interest Expense | $1.18B 5.1% | $1.12B 4.7% | $1.15B 4.7% | $1.13B 4.5% | $1.19B 4.6% | $1.22B 4.7% | $1.32B 5.3% | $697.0M 2.7% | $736.0M 2.9% | $754.0M 2.9% |
| Interest & Investment Income | $98.0M 0.4% | $87.0M 0.4% | $160.0M 0.7% | $70.0M 0.3% | $26.0M 0.1% | $14.0M 0.1% | $42.0M 0.2% | $32.0M 0.1% | $31.0M 0.1% | $13.0M 0.1% |
| Pretax Income | $9.39B 40.3% | $13.66B 56.9% | $10.93B 44.6% | $7.39B 29.4% | $3.82B 14.7% | $6.89B 26.3% | $766.0M 3.1% | $9.34B 36.8% | $9.83B 38.4% | $21.85B 84.9% |
| Income Tax Expense | $2.44B 10.5% | $2.39B 10.0% | $2.80B 11.4% | $1.63B 6.5% | $1.35B 5.2% | $2.44B 9.3% | $2.06B 8.2% | $2.37B 9.4% | -$399.0M -1.6% | $7.61B 29.6% |
| Net Income | $6.95B 29.8% | $11.26B 46.9% | $8.13B 33.2% | $5.76B 23.0% | $2.48B 9.5% | $4.47B 17.1% | -$1.29B -5.1% | $6.96B 27.5% | $10.22B 40.0% | $14.24B 55.3% |
| Per Share | ||||||||||
| EPS (Basic) | $4.12 | $6.54 | $4.57 | $3.19 | $1.34 | $2.40 | $-0.70 | $3.69 | $5.31 | $7.28 |
| EPS (Diluted) | $4.12 | $6.54 | $4.57 | $3.19 | $1.34 | $2.40 | $-0.70 | $3.68 | $5.31 | $7.28 |
| Weighted Avg Shares (Basic) | 1.68B | 1.72B | 1.78B | 1.80B | 1.84B | 1.86B | 1.87B | 1.89B | 1.92B | 1.95B |
| Weighted Avg Shares (Diluted) | 1.68B | 1.72B | 1.78B | 1.80B | 1.84B | 1.86B | 1.87B | 1.89B | 1.92B | 1.95B |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $69.70 today, the market must believe free cash flow compounds 4.2%/yr for a decade (off $8.9B normalized FCF).
The market's 4.2% is more conservative than its 9-yr track record.
2-stage DCF · 1.67B shares · net debt $21.2B
mean 12.8% · volatility σ 25% · implied rate exceeded in 5/9 yrs
Central path = implied 4.2%/yr growth; shaded band = ±1σ (25%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend takes 77% of free cash flow — sustainable but with limited headroom. Last year: $7.0B dividends + $1.0B buybacks = $8.0B returned on $9.1B FCF.
9 consecutive years of dividend increases · 7%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 31%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $4.5B covers the $1.6B due within a year 2.9× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~4.6% on $25.7B of debt.
Cash of $4.5B fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
Nothing notable to watch.
Where each multiple sits in its own 14-yr range · 97th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 3.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 29.1 | 28.2 | 29.9 | 27.4 | 25.7 | 25.4 | 25.3 | 24.0 |
| Gross Profit | 48.3 | 50.6 | 49.8 | 53.8 | 56.8 | 58.3 | 59.8 | 62.5 |
| R&D | 1.0 | 0.7 | 0.5 | 0.6 | 0.6 | 0.9 | 0.9 | 0.8 |
| Operating Income | 35.9 | 41.1 | 41.6 | 44.4 | 47.5 | 47.2 | 46.8 | 42.5 |
| Income Tax | 9.4 | 8.2 | 9.3 | 5.2 | 6.5 | 11.4 | 10.0 | 10.5 |
| Net Income | 27.5 | -5.1 | 17.1 | 9.5 | 23.0 | 33.2 | 46.9 | 29.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MO: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.